Myocardial Perfusion Imaging
1
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Lantheus Medical ImagingDefinity
Kite PharmaRanolazine
GuerbetGadavist 15Ml Solution for Injection
Clinical Trials (3)
Total enrollment: 195 patients across 3 trials
Real-Time Myocardial Perfusion Echocardiography in the ICU
Start: Sep 2017Est. completion: Dec 201924 patients
Phase 4Completed
Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Start: Sep 2010Est. completion: Sep 201281 patients
Phase 4Completed
Dotarem Evaluation for Myocardial Perfusion CMR
Start: Jul 2019Est. completion: Oct 202490 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.